Kids With Iron Deficiency and Scoliosis
Launched by COLUMBIA UNIVERSITY · Sep 12, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether giving iron supplements before surgery can help teenagers with scoliosis who are low in iron. The researchers want to see if taking these supplements can lower the chances of needing a blood transfusion during or after surgery and improve how well patients think and move after the operation. They are looking for participants aged 11 to 26 who have been diagnosed with scoliosis or kyphosis and have low iron levels, as shown by a blood test. To join, candidates must be able to swallow tablets and have a spinal fusion surgery planned within a few weeks.
If you or someone you know qualifies for the study, participants will be asked to take iron supplements before their surgery and may need to attend follow-up visits to assess their recovery. It’s important to know that some individuals may not be eligible if they are already taking iron supplements, have certain health conditions, or are pregnant. Overall, the trial aims to find out if boosting iron levels can lead to better surgical outcomes for young patients with scoliosis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. 11-26 years old;
- • 2. diagnosis of scoliosis or kyphosis;
- • 3. self-reported ability to swallow a tablet;
- • 4. spinal fusion procedure planned approximately 6 to 24 weeks from an orthopedic surgical clinic visit at which patient agrees to phlebotomy for screening blood work;
- • 5. serum ferritin less than or equal to 25 µg/L.
- Exclusion Criteria:
- • 1. taking or planning to take iron-containing supplement on patient's own volition, and not willing to stop for duration of study;
- • 2. taking or planning to take iron-containing supplement as prescribed or recommended under the care of a physician;
- • 3. Hg \<10mg/dL if post-menarchal, Hg \< 11 if premenarchal or male
- • 4. C-reactive protein \> 10 mg/L
- • 5. receiving nutritional support by report in the medical chart;
- • 6. self-reported history of hypersensitivity reaction to iron-containing supplements;
- • 7. self-reported history of or suspected non-iron deficient hematologic disorder;
- • 8. self-reported history of iron overloaded state such as hereditary hemochromatosis or hemosiderosis;
- • 9. objection to receiving red blood cell transfusions;
- • 10. current pregnancy (by self-report);
- • 11. prisoners;
- • 12. patient or parent decides against study participation.
About Columbia University
Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Lisa D Eisler, MD
Principal Investigator
Columbia University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported